Beta Blocker Interruption After Uncomplicated Myocardial Infarction
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 3700 participants.
Also called NCT03498066
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 3,700 participants
- Registry
-
NCT03498066
-
- Other papers using this trial's data
- Beta-Blocker Interruption or Continuation after Myocardial Infarction
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- France
- Registry status
- Completed
Technical summary
Registry record NCT03498066. Randomized; no masking; primary purpose treatment. Start 2018-08-29 (actual); primary completion 2023-10-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Beta Blocker Interruption After Uncomplicated Myocardial Infarction
- Acronym
- AβYSS
- Condition
- Myocardial Infarction
- Intervention (Drug)
- Beta-blockers withdrawal
- Intervention (Drug)
- Continuation of the Betablockers (βB) treatment
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Collaborator
- Groupe Hospitalier Pitie-Salpetriere
Record details
- Record id
cardio:ct-nct03498066- Content hash
7c373ebd73993c7f8c0797ba4ae0163c60b562c83500d2b6698a49d6d812ac3d